14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.63 Thursday, 25th Apr 2024 CGEN stock ended at $1.90. This is 0.524% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.88% from a day low at $1.89 to a day high of $2.02.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Oct 30, 2020 $13.40 $13.59 $12.55 $12.89 1 254 929
Oct 29, 2020 $13.39 $13.89 $13.33 $13.55 911 494
Oct 28, 2020 $13.59 $13.76 $13.27 $13.38 513 077
Oct 27, 2020 $13.99 $14.31 $13.84 $13.98 615 619
Oct 26, 2020 $13.95 $14.30 $13.43 $13.88 690 202
Oct 23, 2020 $14.28 $14.35 $13.79 $14.16 775 323
Oct 22, 2020 $14.07 $14.64 $13.96 $14.27 805 569
Oct 21, 2020 $14.72 $14.97 $13.90 $13.95 1 171 415
Oct 20, 2020 $15.39 $15.78 $14.59 $14.67 1 121 131
Oct 19, 2020 $16.10 $16.25 $15.15 $15.24 1 126 284
Oct 16, 2020 $16.13 $16.60 $15.80 $15.81 758 380
Oct 15, 2020 $17.09 $17.13 $15.90 $16.04 1 268 219
Oct 14, 2020 $18.14 $18.75 $17.40 $17.48 1 303 122
Oct 13, 2020 $17.35 $18.29 $17.21 $17.95 1 244 128
Oct 12, 2020 $17.59 $18.18 $17.25 $17.45 1 214 210
Oct 09, 2020 $17.15 $17.72 $17.03 $17.53 634 418
Oct 08, 2020 $17.14 $17.86 $16.78 $16.93 847 501
Oct 07, 2020 $15.99 $16.98 $15.99 $16.67 891 587
Oct 06, 2020 $15.79 $16.62 $15.79 $15.96 792 046
Oct 05, 2020 $15.30 $16.14 $15.30 $15.97 885 899
Oct 02, 2020 $15.17 $16.30 $15.04 $15.19 1 430 067
Oct 01, 2020 $16.35 $17.13 $16.35 $17.10 671 975
Sep 30, 2020 $16.38 $16.58 $16.13 $16.25 677 786
Sep 29, 2020 $16.07 $16.57 $16.07 $16.32 854 296
Sep 28, 2020 $16.34 $16.59 $15.84 $16.10 872 045
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT